Ensoma Receives Rare Pediatric Disease and Orphan Drug Designations for EN-374 for Treatment of Chronic Granulomatous Disease
Ensoma has received rare pediatric disease and orphan drug designations from the FDA for EN-374 for the treatment of X-CGD.
Hosted on MSN3d
6 Things to Do When You Wake Up If You Have Chronic Inflammation, According to Dietitians
Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...
thorax.bmj6d
Inflammation in preschool cystic fibrosis is of mixed phenotype, extends beyond the lung and is differentially modified by CFTR modulators
Background Early-life inflammation has long been recognised as a key pathophysiological process in the evolution of cystic ...